Weil, Fenwick Guide $1.1B Deal For Calif. Biopharma Co.
Eli Lilly & Co. has agreed to pay roughly $1.1 billion for Dermira Inc., a California-based biopharmaceutical company focused on developing treatments for chronic skin conditions, in a deal stitched together...To view the full article, register now.
Already a subscriber? Click here to view full article